Age can influence hair loss treatment in Japan, but there isn’t a single age cutoff; instead, there are specific guidelines. At our clinics, we see men aged 18 and older, but we do not treat those under 18. Patients aged 18 or 19 must attend with a parent or guardian.
For adult patients, the decision to begin treatment is based more on the scalp examination and health history than solely on the patient’s age.
For people planning to travel to Japan for care, it helps to separate three things: our clinic policy, the labels on Japanese medicines, and what research has shown at different ages. Together, they show when treatment is available and what changes with age.
Age requirements for hair loss treatment
We see patients aged 18 and older; we cannot treat anyone under 18, and patients aged 18 or 19 are generally asked to bring a parent or guardian.
The three age groups at a glance
| Age group | Our clinic | Japanese drug labels |
|---|---|---|
| Under 18 | Not eligible for treatment | Oral finasteride and dutasteride: no established safety or efficacy under 20 |
| 18–19 | Seen with a parent or guardian, as a rule | Same under-20 caution applies |
| 20 and older | Treatment possible after an in-person exam | Labeled for adult men in Japan |
These lines show when care can begin, but a doctor still has to identify the type of hair loss. Conditions other than male pattern hair loss can also cause hair loss. An exam is required at every age.
What Japanese drug labels say by age
Japanese prescribing information indicates that the safety and efficacy of oral finasteride and oral dutasteride have not been established for individuals under 20 years old. Finasteride has no pediatric indication, and dutasteride should not be administered to children.
Topical minoxidil sold in Japanese pharmacies is labeled for adult men aged 20 and older, and its instructions say people under 20 should not use it. These age limits reflect how the medicines were studied rather than anything that changes at age 20.
They matter most for people under 20, because the official information does not give clinicians a clear safety picture in that group. For adults aged 20 and older, the labels still carry cautions, but they no longer set an age limit.
When male pattern hair loss begins
Male pattern hair loss often begins much younger than many men expect. The first signs can appear in the teenage years, when the condition tends to progress slowly.
In one study of 3,897 clinic patients who reported onset at or before age 35, about 7 in 10 said their loss began between ages 21 and 30.1 That is one reason many men first notice changes in their 20s and early 30s.
A two-center record review found 145 cases diagnosed before age 18, with an average age of about 16.2 Hair loss can begin in the teenage years, but a careful diagnosis is needed because other hair and scalp conditions can look similar.
Men who notice hair loss early often have a family history, and early loss can be emotionally distressing.
How doctors diagnose male pattern hair loss
In cases of male pattern hair loss, a doctor can usually identify the pattern by reviewing the patient’s history and conducting a scalp examination using a magnifying tool known as trichoscopy.
This examination highlights variations in hair thickness at the follicle level, which helps in determining an appropriate treatment plan.
How hair loss treatment results can differ by age
Research does not show a fixed upper limit where hair loss treatment stops working. Some areas of the scalp may respond differently at different ages, but the evidence still covers adult men across a wide range.
In a randomized trial of men aged 18 to 60 using finasteride, participants aged 41 to 60 still gained hair at the vertex and mid-scalp over 24 months.3 At the hairline, though, the change in the older group was less clear.
Japanese clinical guidelines describe male pattern hair loss as a condition that begins after puberty and progresses slowly. The same guidelines list oral finasteride, oral dutasteride, and topical minoxidil as first-line options for men.
Most studies enroll adults and report group results. Age alone cannot predict how you will respond to treatment.
Whether you are 25, 45, or 60, the first visit includes hairline photos, a microscope view of the scalp, and a health review. Age may change which areas the doctor watches most closely, but it does not remove the need for that exam.
What to prepare before you contact us
If you are traveling to Japan for care, check the age requirements before your trip. Preparation differs for people under 20 and for adults.
If you are under 20
We can see patients aged 18 or 19 only when a parent or guardian can be present. Before contacting us, take these steps.
- Talk with your parent or guardian about the visit.
- Choose a day when both of you can visit together.
- Prepare a simple note about when you first noticed the change.
If you are under 18, we cannot treat you. Talk with your family first, then see a local dermatologist who can examine the hair loss and help decide whether it is male pattern hair loss or another condition.
If you are 20 or older
Adults do not need to bring a parent, but they should come prepared with up-to-date health information. Please bring a list of the medications you take, any known allergies, and any relevant test results. This information helps the doctor determine which treatments are suitable for you.
At the first visit, you can either begin treatment that day or have the exam and consultation only, then decide at home and return later. The doctor will photograph your hair and scalp and examine the area under magnification before recommending a plan.
If you are planning to visit Japan for care, our team can talk through your age-related questions at our clinics in Tokyo and Yokohama.
Frequently asked questions
- Can I get treatment if I am under 18?
-
No. We do not treat patients under 18. Your first step is to talk with a family member, then see a local dermatologist for a correct diagnosis.
- Do I need a parent at 18 or 19?
-
Yes, as a rule. Patients aged 18 and 19 should come with a parent or guardian. Choose a visit day when that person can join you.
- Is there a maximum age for treatment?
-
We do not set one strict maximum age. A doctor decides whether treatment is appropriate after an exam, a health review, and a conversation about your goals.
- Why do Japanese labels mention age 20?
-
Because safety and efficacy have not been established for oral finasteride or dutasteride in people under 20, and topical minoxidil sold in pharmacies is labeled for men aged 20 and older.
This is why patients who are 18 or 19 need extra care and a parent at the visit. It does not rule out treatment at that age; the doctor still reviews the risks in person.
References
1. Ding, Q., Xu, Y. X., Sun, W. L., Liu, J. J., Deng, Y. Y., Wu, Q. F., Cao, C. Y., Zhou, L. B., Lu, Y., & Fan, W. X. (2020). Early-onset androgenetic alopecia in China: a descriptive study of a large outpatient cohort. The Journal of International Medical Research, 48(3), 300060519897190. https://doi.org/10.1177/0300060519897190
2. Losoya-Jaquez, M. R., Lopez Yañez-Blanco, A., Armendariz-Barragan, Y., Aguilar-Figueroa, N. G., Rudnicka, L., & Sanchez-Dueñas, L. E. (2024). Androgenetic Alopecia in Children and Adolescents: From Trichoscopy to Therapy. Skin Appendage Disorders, 10(2), 123-128. https://doi.org/10.1159/000534844
3. Olsen, E. A., Whiting, D. A., Savin, R., Rodgers, A., Johnson-Levonas, A. O., Round, E., Rotonda, J., Kaufman, K. D., & Male Pattern Hair Loss Study Group (2012). Global photographic assessment of men aged 18 to 60 years with male pattern hair loss receiving finasteride 1 mg or placebo. Journal of the American Academy of Dermatology, 67(3), 379-86. https://doi.org/10.1016/j.jaad.2011.10.027
Blumeyer, A., Tosti, A., Messenger, A., Reygagne, P., Del Marmol, V., Spuls, P. I., Trakatelli, M., Finner, A., Kiesewetter, F., Trüeb, R., Rzany, B., Blume-Peytavi, U., & European Dermatology Forum (2011). Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men. Journal der Deutschen Dermatologischen Gesellschaft, 9 Suppl 6, S1-57. https://doi.org/10.1111/j.1610-0379.2011.07802.x
Griggs, J., Burroway, B., & Tosti, A. (2021). Pediatric androgenetic alopecia: A review. Journal of the American Academy of Dermatology, 85(5), 1267-1273. https://doi.org/10.1016/j.jaad.2019.08.018
Manabe, M., Tsuboi, R., Itami, S., Osada, S. I., Amoh, Y., Ito, T., Inui, S., Ueki, R., Ohyama, M., Kurata, S., Kono, T., Saito, N., Sato, A., Shimomura, Y., Nakamura, M., Narusawa, H., Yamazaki, M., & Drafting Committee for the Guidelines for the Diagnosis and Treatment of Male- and Female-Pattern Hair Loss (2018). Guidelines for the diagnosis and treatment of male-pattern and female-pattern hair loss, 2017 version. The Journal of Dermatology, 45(9), 1031-1043. https://doi.org/10.1111/1346-8138.14470





